EFG INTERNATIONAL FINANCE (GUERNSEY) LIMITED | Market Closed - Swiss Exchange 11:20:00 2024-07-12 am EDT | ||
| 103 USD | +0.27% |
|
| Current month | +0.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 103 | +0.27% |
| 24-07-11 | 102.7 | +0.51% |
| 24-07-10 | 102.2 | +0.22% |
| 24-07-04 | 102 | -0.03% |
| 24-07-03 | 102 | -0.43% |
Delayed Quote Swiss Exchange
Last update July 12, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | LEONTEQ |
| HZAEFG | |
| ISIN | CH1342433484 |
| Date issued | 2024-04-19 |
| Strike | 215.1 $ |
| Maturity | 2026-04-20 (647 Days) |
| Parity | 0.22 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 103 $ |
|---|---|
| Lowest since issue | 100.7 $ |
| Spread | 8.3 $ |
| Spread % | 0.80% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.8
USD
Average target price
317.4
USD
Spread / Average Target
-4.06%
- Stock Market
- Certificates
- HZAEFG Certificat
